Janney Montgomery Scott’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Sell |
256,664
-23,870
| -9% | -$210K | 0.01% | 1151 |
|
|
2025
Q1 | $2.1M | Sell |
280,534
-16,860
| -6% | -$126K | 0.01% | 1139 |
|
|
2024
Q4 | $2.48M | Sell |
297,394
-7,675
| -3% | -$64K | 0.01% | 1062 |
|
|
2024
Q3 | $2.12M | Sell |
305,069
-127,755
| -30% | -$887K | 0.01% | 1118 |
|
|
2024
Q2 | $2.12M | Sell |
432,824
-227,345
| -34% | -$1.11M | 0.01% | 1078 |
|
|
2024
Q1 | $3.83M | Sell |
660,169
-23,262
| -3% | -$135K | 0.01% | 856 |
|
|
2023
Q4 | $4.48M | Buy |
683,431
+9,062
| +1% | +$59.4K | 0.01% | 779 |
|
|
2023
Q3 | $3.25M | Buy |
674,369
+151,599
| +29% | +$731K | 0.01% | 836 |
|
|
2023
Q2 | $2.67M | Sell |
522,770
-5,985
| -1% | -$30.5K | 0.01% | 941 |
|
|
2023
Q1 | $2.91M | Buy |
528,755
+34,725
| +7% | +$191K | 0.01% | 825 |
|
|
2022
Q4 | $2.27M | Buy |
494,030
+14,650
| +3% | +$67.3K | 0.01% | 967 |
|
|
2022
Q3 | $2.99M | Buy |
479,380
+160
| +0% | +$998 | 0.01% | 801 |
|
|
2022
Q2 | $2.17M | Buy |
479,220
+129,100
| +37% | +$584K | 0.01% | 897 |
|
|
2022
Q1 | $1.76M | Buy |
350,120
+64,205
| +22% | +$323K | 0.01% | 972 |
|
|
2021
Q4 | $2.49M | Buy |
285,915
+6,475
| +2% | +$56.4K | 0.01% | 867 |
|
|
2021
Q3 | $2.61M | Buy |
279,440
+20,775
| +8% | +$194K | 0.01% | 826 |
|
|
2021
Q2 | $3.32M | Buy |
258,665
+246,365
| +2,003% | +$3.16M | 0.01% | 730 |
|
|
2021
Q1 | $113K | Buy |
+12,300
| New | +$113K | ﹤0.01% | 2120 |
|
|
2019
Q3 | – | Sell |
-841
| Closed | -$24K | – | 2157 |
|
|
2019
Q2 | $24K | Sell |
841
-800
| -49% | -$22.8K | ﹤0.01% | 2031 |
|
|
2019
Q1 | $44K | Buy |
1,641
+88
| +6% | +$2.36K | ﹤0.01% | 1975 |
|
|
2018
Q4 | $44K | Buy |
+1,553
| New | +$44K | ﹤0.01% | 1914 |
|